Tamsulosin Assisted Ureteral Access Sheath Insertion

Phase 3

• Conditions: Renal Stone; Retrograde Intrarenal Surgery; Urolithiasis
• Interventions: Drug: Tamsulosin

• Registration Number: NCT05197088
• Lead Sponsor: Sengkang General Hospital

Brief Summary

Aim is to study if 1 week of pre operative tamsulosin would enable easier insertion of ureteral access sheath in primary retrograde intrarenal surgery for renal stone disease

Detailed Description

Not available

Study Timeline

• Status Verified: 2022-01
• Study Start: 2022-01-09
• Study First Submitted: 2022-01-09
• Study First Submitted QC: 2022-01-09
• Last Update Submitted: 2022-01-09
• Study First Posted: 2022-01-19
• Last Update Posted: 2022-01-19
• Primary Completion: 2023-03-31
• Study Completion: 2023-07-31

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 110

Inclusion Criteria

• renal stone undergoing retrograde intrarenal surgery

Read More

Exclusion Criteria

• not on tamsulosin or other alpha blockers regularly
• ureteral stricture
• concurrent ureteric stone

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: FACTORIAL

Arm && Interventions

Group	Intervention	Description
1 week of tamsulosin	Tamsulosin	1 week of tamsulosin tablet 400mcg once a night

Primary Outcome Measures

Name	Time	Method
successful insertion of ureteral access sheath to the upper ureter (above the level of SI joint on fluoroscopy)	during operation

Secondary Outcome Measures

Name	Time	Method
grade of ureteric injury after ureteral access sheath removal	during operation
stone free rate	3 months
need for additional procedures	3 months
post operative complications	3 months